Corrigendum to “Advances in vesicular nanocarrier-mediated therapies for hypertrophic scars: mechanistic insights, preclinical evidence and clinical perspectives” [Int. J. Pharm. 693 (2026) 126706]
- DOI
- 10.1016/j.ijpharm.2026.127446
- Published
- 2026-11
- Container
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijpharm.2026.127446,
title = {Corrigendum to “Advances in vesicular nanocarrier-mediated therapies for hypertrophic scars: mechanistic insights, preclinical evidence and clinical perspectives” [Int. J. Pharm. 693 (2026) 126706]},
author = {Mahdieh Abdi and Marjan Ghorbani and Farid Mostafaei and Muhammad Sarfraz and Hadi Valizadeh and Mohammadreza Ranjkesh and Parvin Zakeri-Milani},
year = {2026},
journal = {International Journal of Pharmaceutics},
doi = {10.1016/j.ijpharm.2026.127446},
url = {https://doi.org/10.1016/j.ijpharm.2026.127446}
}RIS
TY - JOUR TI - Corrigendum to “Advances in vesicular nanocarrier-mediated therapies for hypertrophic scars: mechanistic insights, preclinical evidence and clinical perspectives” [Int. J. Pharm. 693 (2026) 126706] AU - Mahdieh Abdi AU - Marjan Ghorbani AU - Farid Mostafaei AU - Muhammad Sarfraz AU - Hadi Valizadeh AU - Mohammadreza Ranjkesh AU - Parvin Zakeri-Milani PY - 2026 JO - International Journal of Pharmaceutics DO - 10.1016/j.ijpharm.2026.127446 UR - https://doi.org/10.1016/j.ijpharm.2026.127446 ER -
APA
Abdi, M., Ghorbani, M., Mostafaei, F., Sarfraz, M., Valizadeh, H., Ranjkesh, M., & Zakeri-Milani, P. (2026). Corrigendum to “Advances in vesicular nanocarrier-mediated therapies for hypertrophic scars: mechanistic insights, preclinical evidence and clinical perspectives” [Int. J. Pharm. 693 (2026) 126706]. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127446
Source records
- crossref · retrieved 2026-09-26T14:20:50.060Z